Baxter, P. The definition and classification of cerebral palsy. Dev. Med Child Neurol. 49, 1–44 (2007).
Rosenbaum, P., Paneth, N., Leviton, A., Goldstein, M. & Bax, M. A report: the definition and classification of cerebral palsy April 2006. Dev. Med Child Neurol. 49, 8–14 (2007).
Konno, R. N., Nigam, N., Wakeling, J. M. & Ross, S. A. The contributions of extracellular matrix and sarcomere properties to passive muscle stiffness in cerebral palsy. Front Physiol. 12, 1–13 (2022).
Ronan, S. & Gold, J. T. Nonoperative management of spasticity in children. Childs Nerv. Syst. 23, 943–956 (2007).
Vova, J. A. Cerebral palsy: an overview of etiology, types and comorbidities. OBM Neurobiol. 6, 1–30 (2022).
Dar H., Stewart K., McIntyre S. & Paget S. Multiple motor disorders in cerebral palsy. Dev. Med. Child Neurol. 2023;1–9.
Lumsden, D. E., Kaminska, M., Tomlin, S. & Lin, J. P. Medication use in childhood dystonia. Eur. J. Paediatr. Neurol. 20, 625–629 (2016).
Lumsden, D. E. et al. Pharmacological management of abnormal tone and movement in cerebral palsy. Arch. Dis. Child 104, 775–780 (2019).
Bohn, E., Goren, K., Switzer, L., Falck-Ytter, Y. & Fehlings, D. Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review update and meta-analysis using GRADE. Dev. Med. Child Neurol. 62, 67 (2020).
Sanger, T. D. Pathophysiology of pediatric movement disorders. J. Child Neurol. 18, 9–24 (2003).
Sanger, T. D., Delgado, M. R., Gaebler-Spira, D., Hallett, M. & Mink, J. W. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 111, 89–97 (2003).
Sheean, G. & McGuire, J. R. Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification. PM R. 1, 827–833 (2009).
Lieber, R. L. & Fridén, J. Muscle contracture and passive mechanics in cerebral palsy. J. Appl. Physiol. 126, 1492–1501 (2019).
Article CAS PubMed Google Scholar
Howard, J. J. & Herzog, W. Skeletal muscle in cerebral palsy: from belly to myofibril. Front. Neurol. 12, 1–15 (2021).
Raghavan, P., Lu, Y., Mirchandani, M. & Stecco, A. Human recombinant hyaluronidase injections for upper limb muscle stiffness in individuals with cerebral injury: a case series. EBioMedicine 9, 306–313 (2016).
Article PubMed PubMed Central Google Scholar
Barrett, R. S. & Barber, L. Impaired muscle growth in spastic cerebral palsy. Dev. Med. Child Neurol. 55, 202 (2013).
Barrett, R. S. & Lichtwark, G. A. Gross muscle morphology and structure in spastic cerebral palsy: a systematic review. Dev. Med Child Neurol. 52, 794–804 (2010).
Howard, J. J., Graham, K. & Shortland, A. P. Understanding skeletal muscle in cerebral palsy: a path to personalized medicine? Dev. Med Child Neurol. 64, 289–295 (2022).
Bekteshi, S. et al. Towards functional improvement of motor disorders associated with cerebral palsy. Lancet Neurol. 22, 229–243 (2023).
Novak, I. et al. State of the evidence traffic lights 2019: systematic review of interventions for preventing and treating children with cerebral palsy. Curr. Neurol. Neurosci. Rep. 20, 1–21 (2020).
Morgan, C. et al. Early intervention for children aged 0 to 2 years with or at high risk of cerebral palsy: international clinical practice guideline based on systematic reviews. JAMA Pediatr. 175, 846–858 (2021).
Article PubMed PubMed Central Google Scholar
Herskind, A., Greisen, G. & Nielsen, J. B. Early identification and intervention in cerebral palsy. Dev. Med Child Neurol. 57, 29–36 (2015).
Tedroff, K., Löwing, K., Haglund-ÅKerlind, Y., Gutierrez-Farewik, E. M. & Forssberg, H. Botulinumtoxin A treatment in toddlers with cerebral palsy. Acta Paediatr. Int J. Paediatr. 99, 1156–1162 (2010).
Gormley, M. et al. Treatment of pediatric spasticity, including children with cerebral palsy, with Botox (onabotulinumtoxinA): Development, insights, and impact. Med (U. S.) 102, E32363 (2023).
Yang H. et al. Safety and efficacy of botulinum toxin type a in children with spastic cerebral palsy aged <2 years: a systematic review. J. Child Neurol. 38, 1–12 (2023).
Vova J. A. et al. A consensus statement on the use of botulinum toxin in pediatric patients. PMR 14, 1116–1142 (2022).
Moreta, M. C. et al. Reliability and validity of the modified Heckmatt scale in evaluating muscle changes with ultrasound in spasticity. Arch. Rehabil. Res. Clin. Transl. 190, S50–S51 (2021).
Multani I., Manji J., Hastings-Ison T., Khot A. & Graham K. Botulinum toxin in the management of children with cerebral palsy. Pediatr Drugs. 139 (2019).
Schless, S. H. et al. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy. Dev. Med. Child Neurol. 61, 783–790 (2018).
Mathevon, L. et al. Muscle structure and stiffness assessment after botulinum toxin type A injection. A systematic review. Ann. Phys. Rehabil. Med. 58, 343–350 (2015).
Article CAS PubMed Google Scholar
Minamoto, V., Suzuki, K., Bremner, S. N., Lieber, R. & Ward, S. R. Dramatic changes in muscle contractile and structural properties after two botulinum toxin injections. Muscle Nerve 52, 649–657 (2015).
Article CAS PubMed PubMed Central Google Scholar
Picelli A. et al. Does botulinum toxin treatment affect the ultrasonographic characteristics of post-stroke spastic equinus? A retrospective pilot study. Toxins. 12, 797 (2020).
Barber, L. E. E., Richard, T. H., Rod, B. & Glen, B. Medial gastrocnemius muscle volume and fascicle length in children aged 2 to 5 years with cerebral palsy. Dev. Med Child Neurol. 53, 543–548 (2011).
Yi Y. G., Jang D. H., Lee D., Oh J. Y. & Han M. H. Botulinum toxin injection in children with hemiplegic cerebral palsy: correction of growth through comparison of treated and unaffected limbs. Toxins. 11, 688 (2019).
Lee D. et al. Changes in muscle mass after botulinum toxin injection in children with spastic hemiplegic cerebral palsy. Toxins. 13, 278 (2021).
Costamagna, D. et al. Botulinum toxin treatment of adult muscle stem cells from children with cerebral palsy and hiPSC-derived neuromuscular junctions. Cells 12, 1–27 (2023).
Li, S., Winston, P. & Mas, M. F. Spasticity treatment beyond botulinum toxins. Phys. Med Rehabil. Clin. N. Am. 35, 399–418 (2024).
Article CAS PubMed Google Scholar
Ilfeld, B. M., Preciado, J. & Trescot, A. M. Novel cryoneurolysis device for the treatment of sensory and motor peripheral nerves. Expert Rev. Med Devices 13, 713–725 (2016).
Article CAS PubMed Google Scholar
Rubenstein J., Harvey A. W., Vincent D. & Winston P. Cryoneurotomy to reduce spasticity and improve range of motion in spastic flexed elbow. A visual vignette. Am. J. Phys. Med. Rehabil. 100030 (2020).
Winston P. et al. Analysis of side effects of cryoneurolysis for the treatment of spasticity. Am. J. Phys. Med. Rehabil. 11, 1008–13 (2023).
Edwards, R. H. T. Physiological analysis of skeletal muscle weakness and fatigue. Clin. Sci. Mol. Med 54, 463–470 (1978).
Zúñiga, L. D. O., López, C. A. G. & González, E. R. Ultrasound elastography in the assessment of the stiffness of spastic muscles: a systematic review. Ultrasound Med. Biol. 47, 1448–1464 (2021).
Bertan, H. et al. Use of shear wave elastography for quantitative assessment of muscle stiffness after botulinum toxin injection in children with cerebral palsy. J. Ultrasound Med. 39, 2327–2337 (2020).
Brandenburg, J. E. et al. Quantifying effect of onabotulinum toxin a on passive muscle stiffness in children with cerebral palsy using ultrasound shear wave elastography. Am. J. Phys. Med. Rehabil. 97, 500–506 (2018).
Article PubMed PubMed Central Google Scholar
Lee, S. S. M., Gaebler-Spira, D., Zhang, L. Q., Rymer, W. Z. & Steele, K. M. Use of shear wave ultrasound elastography to quantify muscle properties in cerebral palsy. Clin. Biomech. 31, 20–28 (2016).
Jardon, M. et al. Utilization of shear wave elastography to quantify and predict response to upper extremity botulinum toxin injections in patients with cerebral palsy: A pilot study. Clin. Neurol. Neurosurg. 230, 107798 (2023).
Comments (0)